A multidisciplinary team of researchers at the Institute for Molecular Medicine Finland (FIMM), and the Helsinki University Central Hospital has developed a novel individualised systems medicine strategy which enables selection of potentially effective cancer therapies for individual patients. Furthermore, this strategy helps in understanding and predicting drug resistance and may pave a path for individualised optimisation of patient therapies in the clinic for various types of cancers. Read more here.
Study mentioned: Pemovska T, et al. Individualized systems medicine strategy to tailor treatments for patients with chemorefractory acute myeloid leukemia. Cancer Discov. 2013 Dec;3(12):1416-29. PMID: 24056683
No comments:
Post a Comment